Congratulations! You now have unlimited access to all articles from The Translational Scientist.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to Solutions/product profiles
digital magazine subscription
Miguel Forte
Miguel Forte is Chief Executive Officer of Zelluna Immunotherapy and Chief Commercialization Officer and Chair of the Commercialization Committee, International Society of Cellular Therapy.